SCHEMBL14370030

SCHEMBL14370030

COC(=O)C(C)N1CCN(C(=O)CCc2ccccc2)CC(NC(=O)CCc2ccccc2)C1=O

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ FAAH O00519 4/20 0.45
▸ CHRNB2 P17787 1/20 0.44
▸ CHRNA4 P43681 1/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ XIAP P98170 1/20 0.43
▸ BIRC3 Q13489 1/20 0.43
▸ BIRC2 Q13490 1/20 0.43
▸ YAP1 P46937 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12914622 1.00 HPGD (0.47) HPGDSMN1; SMN2ALDH1A1L3MBTL1FAAH
SCHEMBL12450938 0.87 FAAH (0.46) HPGDSMN1; SMN2ALDH1A1L3MBTL1FAAH
SCHEMBL8763113 0.84 XIAP (0.43) HPGDSMN1; SMN2ALDH1A1L3MBTL1FAAH
SCHEMBL8763121 0.84 HPGD (0.42) HPGDSMN1; SMN2ALDH1A1FAAHNPC1
SCHEMBL950189 0.82 CASP1 (0.52) HPGDSMN1; SMN2XIAPBIRC3BIRC2
SCHEMBL14370033 0.82 CASP1 (0.52) HPGDSMN1; SMN2XIAPBIRC3BIRC2
SCHEMBL12946457 0.82 CASP1 (0.42) HPGDSMN1; SMN2ALDH1A1FAAHNPC1
SCHEMBL950190 0.82 CASP1 (0.52) HPGDSMN1; SMN2XIAPBIRC3BIRC2
SCHEMBL12914620 0.82 CASP1 (0.52) HPGDSMN1; SMN2XIAPBIRC3BIRC2
SCHEMBL12450522 0.81 CASP1 (0.46) HPGDSMN1; SMN2FAAHNPC1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7288624-B2 Inhibitors of interleukin-1β converting enzyme VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-10-30 — — US disclosed
Send feedback